Cinnamaldehyde prodrug for rheumatoid arthritis treatment
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- B77
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- The reactive oxygen species-responsive cinnamaldehyde-penicillamine prodrug forms nanoparticles that release two drugs without any side products at inflamed sites, effectively treating rheumatoid arthritis without noticeable side effects.
- Simplified description
- Scientists have developed a new treatment for rheumatoid arthritis using tiny particles that release two drugs precisely at inflamed areas, minimizing side effects.
Inventors
Weiping WANG
inventor 3727293028_3331
Yaming ZHANG
inventor 3727293028_3332
The University of Hong Kong
inventor 3727293028_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.